REQUEST A DEMO
Total
USD $0.00
Search more companies

Farma Vita Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Farma Vita Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Farma Vita Sas is based in Colombia. The head office is in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on March 15, 2011. 1 (2024) employees currently work for Farma Vita Sas. In 2023, the company reported a net sales revenue increase of 46.74%. Its total assets grew by 41.99% over the same period. In 2023, Farma Vita Sas’s net profit margin increased by 6.54%.

Headquarters
Calle 127 16 A -76 Ofc 303
Bogota D.C.; Bogota D.C; Postal Code: 1013

Contact Details: Purchase the Farma Vita Sas report to view the information.

Basic Information
Total Employees:
Purchase the Farma Vita Sas report to view the information.
Outstanding Shares:
Purchase the Farma Vita Sas report to view the information.
Incorporation Date:
March 15, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Farma Vita Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
46.74%
Total operating revenue
46.74%
Operating profit (EBIT)
276.64%
Net Profit (Loss) for the Period
278.24%
Total assets
41.99%
Total equity
38.63%
Operating Profit Margin (ROS)
15.94%
Net Profit Margin
6.54%
Return on Equity (ROE)
17.65%
Quick Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?